非瓣膜性心房颤动患者的综合治疗  

Integrated treatment of patients with nonvalvular atrial fibrillation

作　　者：秦俊楠 张丽晖[1] 王静[1] 王越[1] 黄小宇 QIN Jun-Nan;ZHANG Li-Hui;WANG Jing;WANG Yue;HUANG Xiao-Yu(Department of Cardiology,Third Hospital of Shanxi Medical University,Shanxi Bethune Hospital,Shanxi Academy of Medical Sciences,Tongji Shanxi Hospital,Taiyuan 030032,China)

机构地区：[1]山西医科大学第三医院·山西白求恩医院·山西医学科学院·同济山西医院心血管内科,太原030032

出　　处：《中华老年多器官疾病杂志》2022年第8期625-629,共5页Chinese Journal of Multiple Organ Diseases in the Elderly

基　　金：山西省留学回国人员科技活动择优资助项目(2017-1389);山西省应用基础研究项目(201801D121202);山西省回国留学人员科研资助项目(2020-179)。

摘　　要：心房颤动(AF)是临床上最常见的心律失常类型,既往AF管理侧重于AF相关栓塞预防以及心室率和节律的控制。近年来,AF综合管理的理念逐渐普及。AF综合管理强调在做好AF相关栓塞预防及症状控制的基础上,同时关注患者生活质量的改善以及合并症的管理,以进一步改善患者的预后。本文就非瓣膜性心房颤动患者的抗凝治疗、症状管理及危险因素的控制作一综述。Atrial fibrillation(AF)is the most common type of arrhythmia clinically,and previous AF management has focused on the prevention of AF-related embolism and the control of ventricular rate and rhythm.In recent years,the concept of integrated management of AF is gradually popularized.Integrated management of AF emphasizes the prevention of AF-related embolism and symptom control,as well as the improvement of patients′quality of life and the treatment of complications at the same time,so as to further improve the prognosis of patients.This article reviews the anticoagulant therapy,symptom management,and control of risk factors in patients with nonvalvular atrial fibrillation.

关 键 词：非瓣膜性心房颤动 抗凝治疗 射频消融 左心耳封堵 综合管理 

分 类 号：R541.7[医药卫生—心血管疾病]